A 36-year-old woman with well-controlled type 1 diabetes mellitus reported hyperglycemia (plasma glucose peaked at 21.3 mmol/L) after her first injection with intralesional triamcinolone acetonide for alopecia areata.
Conclusion:
Intralesional corticosteroids are used to maximize local effect while presumably minimizing systemic complications. This adverse effect is an important consideration when treating patients with insulin-dependent diabetes mellitus, and it would be reasonable to counsel patients of such a possibility.
Get full access to this article
View all access options for this article.
References
1.
CallenJP. Intralesional corticosteroids. J Am Acad Dermatol1981;4:149–51, doi:10.1016/S0190-9622(81)70017-3.
GomezECFrostP. Induction of glycosuria and hyperglycemia by topical corticosteroid therapy. Arch Dermatol1976;112:1559–62, doi:10.1001/archderm.1976.01630350035009.
